e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
Simon M. Collin, Gerard de Vries, Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Sarah R. Anderson, Dominik Zenner
Source:
Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
Journal Issue:
December
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Simon M. Collin, Gerard de Vries, Knut Lönnroth, Giovanni Battista Migliori, Ibrahim Abubakar, Sarah R. Anderson, Dominik Zenner. Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes. Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
Source: Eur Respir J 2012; 39: 619-625
Year: 2012
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Source: Eur Respir J, 53 (1) 1802077; 10.1183/13993003.02077-2018
Year: 2019
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis
Source: Eur Respir J 2002; 19: 765-775
Year: 2002
Drug-resistant tuberculosis in the European Union and European economic area
Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Year: 2015
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
Fighting tuberculosis in the EU/EEA: towards the new European Union standards on tuberculosis care
Source: Eur Respir J 2016; 48: 1278-1281
Year: 2016
European Union Standards for Tuberculosis Care
Source: Eur Respir J 2012; 39: 807-819
Year: 2012
Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019
Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease
Source: Eur Respir J 2016; 47:1345-1347
Year: 2016
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation
Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018
Year: 2019
ERS/ECDC updated European Union standards of tuberculosis care
Source: International Congress 2018 – Important changes in the management of tuberculosis
Year: 2018
European Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendations
Source: Eur Respir J, 52 (5) 1801617; 10.1183/13993003.01617-2018
Year: 2018
Management of tuberculosis in the European Union: a multicentre audit
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018
Tuberculosis and HIV co-infection in European Union and European Economic Area countries
Source: Eur Respir J 2011; 38: 1382-1392
Year: 2011
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
Source: Eur Respir J, 53 (6) 1900391; 10.1183/13993003.00391-2019
Year: 2019
The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis
Source: Breathe, 13 (3) e65; 10.1183/20734735.005517
Year: 2017
Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium
Source: Eur Respir J, 51 (5) 1702604; 10.1183/13993003.02604-2017
Year: 2018
Collaborative tuberculosis/HIV activities in the European Region
Source: ERJ Open Res, 7 (1) 00721-2020; 10.1183/23120541.00721-2020
Year: 2021
Italian Presidency of the EU: health priorities
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept